Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease
暂无分享,去创建一个
Christine T. O. Nguyen | Pedro Rosa-Neto | Jean-Philippe Sylvestre | Frédéric Lesage | Mohamed Dirani | Christopher Fluke | Jean-Paul Soucy | Xavier Hadoux | Sulantha Mathotaarachchi | Serge Gauthier | Christopher Rowe | Colin L Masters | Jeremiah K. H. Lim | Bang V Bui | Christine T O Nguyen | Alice Pébay | Victor L Villemagne | C. Rowe | S. Gauthier | C. Masters | J. Crowston | J. Soucy | Z. Nasreddine | C. Fluke | F. Lesage | P. Rosa-Neto | V. Villemagne | Jeremiah K H Lim | B. Bui | A. Pébay | X. Hadoux | P. van Wijngaarden | S. Mathotaarachchi | Jason Ha | J. Sylvestre | S. Beaulieu | J. Arbour | Marc‐André Rhéaume | C. Fowler | M. Dirani | S. Loi | Flora Hui | Sophie Chevalier | Jason Ha | Samantha Loi | Christopher J Fowler | Edward N Taylor | Ziad S Nasreddine | Jean Daniel Arbour | Marc-André Rhéaume | Sylvain Beaulieu | Robert Williamson | Jonathan G Crowston | Peter van Wijngaarden | Sophie Chevalier | Robert Williamson | Flora Hui | Edward N. Taylor
[1] I. Deary,et al. Retinal image analysis: Concepts, applications and potential , 2006, Progress in Retinal and Eye Research.
[2] Zhikuan Yang,et al. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice. , 2009, The American journal of pathology.
[3] R. C. Macridis. A review , 1963 .
[4] Alexei Verkhratsky,et al. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease. , 2014, Experimental eye research.
[5] M. Tso,et al. Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. , 1995, Investigative ophthalmology & visual science.
[6] M. Schwartz,et al. The retina as a window to the brain—from eye research to CNS disorders , 2013, Nature Reviews Neurology.
[7] M. Ohno,et al. Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.
[8] R. Vassar,et al. Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation , 2013, Molecular Neurodegeneration.
[9] Aileen I. Pogue,et al. Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease , 2011, Neuroreport.
[10] M. Ohno,et al. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model , 2009, Neurobiology of Disease.
[11] Christine T. O. Nguyen,et al. Retinal biomarkers provide “insight” into cortical pharmacology and disease☆,☆☆ , 2017, Pharmacology & therapeutics.
[12] D Marr,et al. Theory of edge detection , 1979, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[13] Bunyarit Uyyanonvara,et al. Blood vessel segmentation methodologies in retinal images - A survey , 2012, Comput. Methods Programs Biomed..
[14] Geraint Rees,et al. Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline: A Study Using Optical Coherence Tomography , 2018, JAMA neurology.
[15] Christine T. O. Nguyen,et al. The Eye As a Biomarker for Alzheimer's Disease , 2016, Frontiers in neuroscience.
[16] Swati S. More,et al. Early Detection of Amyloidopathy in Alzheimer's Mice by Hyperspectral Endoscopy. , 2016, Investigative ophthalmology & visual science.
[17] Jean-Michel Roger,et al. Comparison of the efficacy of spectral pre-treatments for wheat and weed discrimination in outdoor conditions , 2014 .
[18] S. Jacques. Optical properties of biological tissues: a review , 2013, Physics in medicine and biology.
[19] A. Savitzky,et al. Smoothing and Differentiation of Data by Simplified Least Squares Procedures. , 1964 .
[20] L. Zangwill,et al. Glaucoma detection using scanning laser polarimetry with variable corneal polarization compensation. , 2003, Archives of ophthalmology.
[21] Swati S. More,et al. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline. , 2015, ACS chemical neuroscience.
[22] Keith L Black,et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. , 2017, JCI insight.
[23] P. Visser,et al. Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis , 2017, Alzheimer's & dementia.
[24] C. Masters,et al. Subcellular localization of the Alzheimer's disease amyloid precursor protein and derived polypeptides expressed in a recombinant yeast system. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[25] F. Delori,et al. Spectral reflectance of the human ocular fundus. , 1989, Applied optics.
[26] Alexander J. Rivest,et al. Characterization of β amyloid assemblies in drusen: The deposits associated with aging and age-related macular degeneration , 2004 .
[27] S. Keel,et al. Emerging ocular biomarkers of Alzheimer disease , 2017, Clinical & experimental ophthalmology.
[28] Walter Stark,et al. Beta‐Amyloid, Phospho‐Tau and Alpha‐Synuclein Deposits Similar to Those in the Brain Are Not Identified in the Eyes of Alzheimer's and Parkinson's Disease Patients , 2014, Brain pathology.
[29] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[30] T. Wong,et al. Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[31] B. Hyman,et al. Absence of Alzheimer Disease Neuropathologic Changes in Eyes of Subjects With Alzheimer Disease , 2017, Journal of neuropathology and experimental neurology.
[32] Christopher C Rowe,et al. Biochemically-defined pools of amyloid-&bgr; in sporadic Alzheimer’s disease: correlation with amyloid PET , 2017, Brain : a journal of neurology.
[33] P. Avanzini,et al. Melanopsin retinal ganglion cell loss in Alzheimer disease , 2015, Annals of neurology.
[34] J. Hardy,et al. The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.
[35] Daniel L. Farkas,et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model , 2011, NeuroImage.
[36] J. J. Vos,et al. Spectral transmission of the human ocular media. , 1974, Vision research.
[37] D M Snodderly,et al. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. , 1984, Investigative ophthalmology & visual science.
[38] K. Ashe,et al. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. , 2008, Investigative ophthalmology & visual science.
[39] Jean-Philippe Sylvestre,et al. A prototype hyperspectral system with a tunable laser source for retinal vessel imaging. , 2013, Investigative ophthalmology & visual science.
[40] Clive N Svendsen,et al. Ocular changes in TgF344-AD rat model of Alzheimer's disease. , 2014, Investigative ophthalmology & visual science.
[41] I. Deary,et al. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures , 2005, Journal of anatomy.
[42] M. Aschner,et al. Untangling the Manganese-α-Synuclein Web , 2016, Front. Neurosci..
[43] C. Masters,et al. Generation of a recombinant Fab antibody reactive with the Alzheimer's disease‐related Aβ peptide , 2002, Clinical and experimental immunology.
[44] J. Roger,et al. DROP-D: Dimension reduction by orthogonal projection for discrimination , 2015 .
[45] R M Hoar,et al. Embryology of the eye. , 1982, Environmental health perspectives.
[46] G. Zonios,et al. Skin melanin, hemoglobin, and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy. , 2001, The Journal of investigative dermatology.
[47] Yogesan Kanagasingam,et al. Ocular biomarkers for early detection of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[48] Colin L. Masters,et al. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.
[49] E. Mufson,et al. Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease. , 2009, Investigative ophthalmology & visual science.
[50] T. Wong,et al. Imaging retina to study dementia and stroke , 2017, Progress in Retinal and Eye Research.
[51] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[52] Rebecca Sinn,et al. An eye on eye development , 2013, Mechanisms of Development.
[53] Andrea Pavesi,et al. A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors. , 2017, JCI insight.
[54] Y. Benjamini,et al. Adaptive linear step-up procedures that control the false discovery rate , 2006 .